Growth Hormone Deficiency in Adults Treatment & Management
Growth hormone (GH) replacement therapy is provided in the form of human recombinant GH. This is available in subcutaneous injection form. The starting dose of GH depends on the age and clinical condition of the patient. A dose regimen that is based on age along with dose titration has been associated with less adverse effects compared with a weight-based regimen.  The following regimen is suggested  :
- Age younger than 30 years: 0.4-0.5 mg/day (may be higher for patients transitioning from pediatric treatment)
- Age 30-60 years: 0.2-0.3 mg/day
- Age >60 years or those with diabetes mellitus or prediabetes: 0.1-0.2 mg/day
For patients with adherence issues, a less frequent dose regimen such as alternate days or 3 times per week using the same total weekly dosage can be used. 
Follow-up is usually planned at intervals of 1-2 months when the dose of GH can be adjusted by increments of 0.1-0.2 mg/day based on the clinical response, serum insulin-like growth factor-1 (IGF-1) levels, and side effects. Longer time intervals and smaller dose increments are suggested for older patients.
Serum IGF-1 levels are the main determinant for adjusting the dose of GH. No studies are available to guide this decision. A commonly used target is the upper half of the normal range appropriate for age and sex, unless significant side effects develop. 
Once maintenance doses of GH are achieved, follow-up is provided at intervals of 6 months. Monitoring includes clinical evaluation, assessment of side effects, and measurement of serum IGF-1, fasting glucose, and lipid profile. Quality of life (QOL) is also assessed using standardized questionnaires. If the initial bone mineral density findings, measured by dual-energy x-ray absorptiometry (DXA) scanning, are abnormal, repeat testing at intervals of 2-3 years is recommended. 
No studies are available regarding the optimal length of GH replacement therapy. Patients with childhood GH deficiency who attained adult height and had persistent deficiency on retesting should continue to receive GH therapy. 
GH therapy can also be continued indefinitely if benefits such as significant improvement in QOL and objective improvements in biochemistry and body composition are observed. If no objective or subjective benefits are seen after 1 year of treatment, discontinuation of GH therapy should be considered. 
If you've got hoop dreams 6' is short...likely too short.Better question what fucking parent would put their kid on GH - script from a doctor was it - because 6 feet is really short?
Maybe he bought script GH and stuck it in his kid but ask yourself why? I will stop there as I’m getting really angry at the irresponsibility.
Did he get any taller?Would assume he is done.My son grew 5 inches in just under 18 months. Between 14 and 16 he grew from 5’11 to 6’4. And I don’t think he is done yet.
He also went from 145-180 lbs
No GH but he goes through a ton of steak, salmon and pizza lol
With their natural test levels at that age, if they are active and have a caloric surplus of quality protein they can grow like crazy.
Sent from my iPhone using Tapatalk
Yes he appears to have stopped growing taller at 6'4. He just turned 17. He is now getting thicker by the day....he is right around 190lbs and that has been on a stead increase for the past year or so. He lifts 3 days per week on an upper/lower split. Still eating us out of house and home LOLDid he get any taller?Would assume he is done.